Abstract

BST-2/tetherin is a cellular host factor capable of restricting the release of a variety of enveloped viruses, including HIV-1. Structurally, BST-2 consists of an N-terminal cytoplasmic domain, a transmembrane domain, an ectodomain, and a C-terminal membrane anchor. The BST-2 ectodomain encodes three cysteine residues in its N-terminal half, each of which can contribute to the formation of cysteine-linked dimers. We previously reported that any one of the three cysteine residues is sufficient to produce functional BST-2 dimers. Here we investigated the importance of cysteine positioning on the ectodomain for functional dimerization of BST-2. Starting with a cysteine-free monomeric form of BST-2, individual cysteine residues were reintroduced at various locations throughout the ectodomain. The resulting BST-2 variants were tested for expression, dimerization, surface presentation, and inhibition of HIV-1 virus release. We found significant flexibility in the positioning of cysteine residues, although the propensity to form cysteine-linked dimers generally decreased with increasing distance from the N terminus. Interestingly, all BST-2 variants, including the one lacking all three ectodomain cysteines, retained the ability to form non-covalent dimers, and all of the BST-2 variants were efficiently expressed at the cell surface. Importantly, not all BST-2 variants capable of forming cysteine-linked dimers were functional, suggesting that cysteine-linked dimerization of BST-2 is necessary but not sufficient for inhibiting virus release. Our results expose new structural constraints governing the functional dimerization of BST-2, a property essential to its role as a restriction factor tethering viruses to the host cell.

Highlights

  • BST-2 forms covalently linked dimers and inhibits virus release

  • Our results expose new structural constraints governing the functional dimerization of BST-2, a property essential to its role as a restriction factor tethering viruses to the host cell

  • We performed a mutagenesis study where cysteine residues were reintroduced at multiple positions along the ectodomain of a BST-2 variant, C3A, in which all three naturally occurring cysteines required for dimerization had previously been mutated to alanine [16]

Read more

Summary

Background

BST-2 forms covalently linked dimers and inhibits virus release. Results: Cysteine residues are not required for BST-2 homodimerization but are critical for antiviral activity. Structural studies of the BST-2 ectodomain have confirmed the importance of cysteine-linked dimerization for antiviral function (18 –21). These models indicate that the disulfide bonds between parallel subunits that form dimers are important for stabilizing the structure of the irregular coiled-coil located in the C-terminal region of the ectodomain. These structural studies show BST-2-forming parallel dimers, they suggest the formation of tetramers, the precise function and importance of which remain to be further determined (19 –21). Our results expose new structural constraints governing the functional dimerization of BST-2, a property essential to its role as a restriction factor tethering viruses to the host cell

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call